Amarin | AMRN - PE Price to Earnings

Stock Price
14.31
Daily Change
-0.28 -1.92%
Monthly
-2.52%
Yearly
37.20%
Q2 Forecast
13.88

Amarin reported 91.05 in PE Price to Earnings for its fiscal quarter ending in June of 2023.





Pe Change Date
AbbVie 24.03 86.23 Dec/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Amarin 91.05 88.3 Jun/2023
AstraZeneca 27.29 5.8 Dec/2025
BioCryst Pharmaceuticals 6.06 1.07K Dec/2025
Esperion Therapeutics 129.79 129 Dec/2024
GlaxoSmithKline 11.15 0.29 Dec/2025
Halozyme Therapeutics 23.16 7.7 Dec/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Neurocrine Biosciences 835.47 802.2 Dec/2025
Novartis 17.85 2.11 Dec/2025